Sentences with phrase «possible related litigation»

Not exact matches

STEVENSON, Md. --(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of DCT Industrial Trust Inc. (NYSE: DCT)(«DCT Industrial» or the «Company») relating to the proposed buyout of DCT Industrial by Prologis, Inc..
Actual results may vary materially from those expressed or implied by forward - looking statements based on a number of factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.
Important factors that could cause actual results to differ materially from those expressed or implied by such forward - looking statements include, without limitation, possible product defects and product liability, risks related to international sales and potential foreign currency exchange fluctuations, the initiation or outcome of litigation, acts or potential acts of terrorism, international conflicts, significant fluctuations of quarterly operating results, changes in Canadian and foreign laws and regulations, continued acceptance of RIM's products, increased levels of competition, technological changes and the successful development of new products, dependence on third - party networks to provide services, dependence on intellectual property rights, and other risks and factors detailed from time to time in RIM's periodic reports filed with the United States Securities and Exchange Commission, and other regulatory authorities.
Question: In order to prevent future controversy and possible litigation, will you please justify constitutionally your legal right to be President of the United States as it relates to your natural born status.
The feasible responses seem to be (i) move into higher - end work, often of an advisory or highly specialist nature: Jeremy Robinson, aviation and competition law partner at Gates and Partners, solicitors, believes that the competition in his practice area does not come, and is unlikely to come, from PLFs or ABSs anytime soon; (ii) form collaborations short of ABSs or multi-disciplinary practices with complementary non-solicitor businesses (Martyn Taylor, MD of respected solicitors agency, Ashley Taylors, has noticed a huge increase in the number of solicitors» firms looking to work on litigation - related joint projects with Ashley Taylors; (iii) to the extent possible adopt the practices of more successful competitors; (iv) innovate.
This inherently resulted in a greater propensity by parties to seek somebody to blame if possible, leading to an increase in property related professional negligence litigation across the professions generally.
Because of its litigation background, the focus of the firm's FCPA practice is conducting internal investigations for corporations when FCPA - related issues are discovered, and, when appropriate, further advising on the self - disclosure to and possible enforcement actions brought by U.S. and foreign regulators.
While the various possible causes of the district court litigation slow - down, including the Alice decision, the rise of PTAB reviews, among other developments (e.g. the Highmark / Octane case decided by the Supreme Court in April 2014, relating to attorneys fees) remain difficult to precisely weigh, it's clear after six months of lackluster business that the landscape is shifting.
Additionally, our lawyers understand the regulatory process and have supported clients with supplemental reporting following clinical trial claims, documentation for PMA and 510 (k) device litigation, and with regulatory filings involving inquiries relating to possible adverse events.
• In terms of using Trusts to reduce Estate Duty, Capital Gains Tax, Executors Fees and other related costs upon death — this would remain intact (unaffected) • In terms of using Trusts to provide for a virtually seamless transition of wealth upon death to the next generation by avoiding frozen Estate issues and bureaucratic delays — this would remain intact (unaffected) • In terms of using Trusts to reduce exposure to asset loss through litigation / divorce and so on — this would remain intact (unaffected) • In terms of using Trusts to reduce Income Tax using the «Conduit Principle» — this would not be possible any longer, but there are several other methods that can be used to reduce Income Tax.
a b c d e f g h i j k l m n o p q r s t u v w x y z